| The clinical approach towards chondrosarcoma H Gelderblom, PCW Hogendoorn, SD Dijkstra, CS Van Rijswijk, AD Krol, ... The oncologist 13 (3), 320-329, 2008 | 563 | 2008 |
| Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up PG Casali, L Jost, P Reichardt, M Schlemmer, JY Blay Annals of Oncology 20, iv64-iv67, 2009 | 499* | 2009 |
| Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome TC Pansuriya, R Van Eijk, P d'Adamo, MAJH Van Ruler, ML Kuijjer, ... Nature genetics 43 (12), 1256-1261, 2011 | 404 | 2011 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv51-iv67, 2018 | 359 | 2018 |
| Multiple osteochondromas JVMG Bovée Orphanet journal of rare diseases 3 (1), 1-7, 2008 | 341 | 2008 |
| Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA VL Luks, N Kamitaki, MP Vivero, W Uller, R Rab, JVMG Bovée, KL Rialon, ... The Journal of pediatrics 166 (4), 1048-1054. e5, 2015 | 299 | 2015 |
| Cartilage tumours and bone development: molecular pathology and possible therapeutic targets JVMG Bovée, PCW Hogendoorn, JS Wunder, BA Alman Nature Reviews Cancer 10 (7), 481-488, 2010 | 236 | 2010 |
| Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data L Wang, T Motoi, R Khanin, A Olshen, F Mertens, J Bridge, PD Cin, ... Genes, Chromosomes and Cancer 51 (2), 127-139, 2012 | 214 | 2012 |
| Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment JVMG Bovée, AM Cleton-Jansen, AHM Taminiau, PCW Hogendoorn The lancet oncology 6 (8), 599-607, 2005 | 203 | 2005 |
| EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas JVMG Bovée, AM Cleton-Jansen, W Wuyts, G Caethoven, AHM Taminiau, ... The American Journal of Human Genetics 65 (3), 689-698, 1999 | 199 | 1999 |
| Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array RC Slieker, SD Bos, JJ Goeman, JVMG Bovée, RP Talens, ... Epigenetics & chromatin 6 (1), 1-12, 2013 | 197 | 2013 |
| The clinical approach toward giant cell tumor of bone L van der Heijden, PDS Dijkstra, MAJ van de Sande, JR Kroep, RA Nout, ... The oncologist 19 (5), 550, 2014 | 175 | 2014 |
| Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas J Zedenius, C Larsson, U Bergholm, J Bovee, A Svensson, B Hallengren, ... The Journal of Clinical Endocrinology & Metabolism 80 (10), 3088-3090, 1995 | 166 | 1995 |
| Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors D Eefting, YM Schrage, MJA Geirnaerdt, S Le Cessie, AHM Taminiau, ... The American journal of surgical pathology 33 (1), 50-57, 2009 | 164 | 2009 |
| Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma JVMG Bovée, LJCM van den Broek, AM Cleton-Jansen, ... Laboratory investigation 80 (12), 1925-1933, 2000 | 160 | 2000 |
| Enchondromatosis: insights on the different subtypes TC Pansuriya, HM Kroon, JVMG Bovée International journal of clinical and experimental pathology 3 (6), 557, 2010 | 156 | 2010 |
| Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature JVMG Bovée, RO van der Heul, AHM Taminiau, PCW Hogendoorn Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 155 | 1999 |
| Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients SHM Verdegaal, JVMG Bovée, TC Pansuriya, RJ Grimer, H Ozger, ... The oncologist 16 (12), 1771, 2011 | 147 | 2011 |
| CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study C Colombo, R Miceli, AJ Lazar, F Perrone, RE Pollock, A Le Cesne, ... Cancer 119 (20), 3696-3702, 2013 | 138 | 2013 |
| Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ... Annals of Oncology 29, iv79-iv95, 2018 | 137 | 2018 |
